GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results
Suzhou Genhouse Bio Co., Ltd.
Suzhou Genhouse Bio Co., Ltd.
Jiangxi Provincial Cancer Hospital
West China Hospital
Ottawa Hospital Research Institute
Chinese PLA General Hospital
Universitair Ziekenhuis Brussel
Centre hospitalier de l'Université de Montréal (CHUM)
University of Virginia
Jiangxi Provincial Cancer Hospital
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Tongji Hospital
Icahn School of Medicine at Mount Sinai
University of Virginia
Kuwait Cancer Control Center
Northwestern University
Sun Yat-sen University
Sixth Affiliated Hospital, Sun Yat-sen University
Poitiers University Hospital
National Cancer Centre, Singapore
Nanfang Hospital, Southern Medical University
Seoul St. Mary's Hospital
University Hospital, Ghent
ISA Pharmaceuticals
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Fudan University
Fudan University
University Medical Center Groningen
Ruijin Hospital
Sichuan University
Qilu Pharmaceutical Co., Ltd.
Sun Yat-sen University
Nanfang Hospital, Southern Medical University
Nanfang Hospital, Southern Medical University
National Cancer Institute, Naples
National Cancer Institute, Egypt
Sun Yat-sen University
The Netherlands Cancer Institute
European Organisation for Research and Treatment of Cancer - EORTC
Rutgers, The State University of New Jersey
OncoResponse, Inc.
Olivia Newton-John Cancer Research Institute
Rigshospitalet, Denmark
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Sichuan Cancer Hospital and Research Institute
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Massachusetts General Hospital
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Nanfang Hospital, Southern Medical University
Centre Georges Francois Leclerc